Main Page
From LipidomicsWiki
(Difference between revisions)
Line 2: | Line 2: | ||
- | + | <br> | |
Line 20: | Line 20: | ||
-----------------------------------> | -----------------------------------> | ||
+ | |||
+ | |||
{{Header|violet|title=Browse LipidomicNet-Wiki | {{Header|violet|title=Browse LipidomicNet-Wiki | ||
|link= | |link= | ||
Line 35: | Line 37: | ||
- | <br> | + | <br> |
+ | <br> | ||
- | |- | + | <br> |
- | | width="65%" valign="top" | <!--------------------------------- | + | |- |
+ | | width="65%" valign="top" | <!--------------------------------- | ||
Task Forces | Task Forces | ||
-----------------------------------> | -----------------------------------> | ||
+ | |||
{{Header|yellow|title=Consortium | {{Header|yellow|title=Consortium | ||
|link= | |link= | ||
Line 54: | Line 59: | ||
- | <br> | + | <br> |
+ | <br> | ||
- | |} | + | <br> |
- | <!------------------------------------- | + | |} |
+ | <!------------------------------------- | ||
Right sided column | Right sided column | ||
----------------------------------------> | ----------------------------------------> | ||
+ | |||
<br> | <br> | ||
+ | <br> | ||
- | | style="border: 1px solid rgb(206, 223, 242); vertical-align: top; background-color: rgb(255, 255, 255); -moz-border-radius: 10px 10px 10px 10px;" class="MainPageBG" | <!-- <div style="margin: 4px 4px 2px 4px; text-align: left;"> --> | + | <br> |
+ | | style="border: 1px solid rgb(206, 223, 242); vertical-align: top; background-color: rgb(255, 255, 255); -moz-border-radius: 10px 10px 10px 10px;" class="MainPageBG" | <!-- <div style="margin: 4px 4px 2px 4px; text-align: left;"> --> | ||
+ | |||
{| cellspacing="5" cellpadding="2" width="100%" style="vertical-align: top; background-color: rgb(255, 255, 255); -moz-border-radius: 10px 10px 10px 10px;" class="FCK__ShowTableBorders" | {| cellspacing="5" cellpadding="2" width="100%" style="vertical-align: top; background-color: rgb(255, 255, 255); -moz-border-radius: 10px 10px 10px 10px;" class="FCK__ShowTableBorders" | ||
|- | |- | ||
Line 86: | Line 97: | ||
- | <br> | + | <br> |
+ | <br> | ||
+ | |||
+ | |||
+ | <br> | ||
Line 105: | Line 120: | ||
- | <br> | + | <br> |
+ | <br> | ||
+ | |||
+ | |||
+ | <br> | ||
Line 126: | Line 145: | ||
- | <br> | + | <br> |
+ | <br> | ||
+ | |||
+ | |||
+ | <br> | ||
|} | |} | ||
- | |} | + | |} |
Revision as of 14:39, 23 June 2011
LipidomicNet Wiki is a knowledge base managed within the EU Framework 7 project "LipidomicNet" in close collaboration with LIPID MAPS and Lipid Bank - Japan LipidomicNet Wiki lives from the contribution of people interested in Lipidomics. All members of the Lipidomics Expertise Platform (LEP) are allowed to edit and add content to LipidomicNet-Wiki. Therefore you are encouraged to register to the LEP and to contribute to the emerging field of Lipidomics (more about LipidomicsWiki).